My Quote Request
No products added yet
6505-01-219-1084
20 Products
NDC00535-0011-01
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN, MFG P/N
6505012191084
NSN
6505-01-219-1084
NDC00535-0011-01
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN, MFG P/N
6505012191084
NSN
6505-01-219-1084
MFG
FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BUTALBITAL ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 40.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT
FEATURES PROVIDED: TAMPER PROOF
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUTALBITAL ACETAMINOPHEN AND CAFFEINE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00535-0011-01
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN
6505-01-219-1084
MFG
FOREST PHARMACEUTICALS INC SUB OF FOREST LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BUTALBITAL ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 40.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT
FEATURES PROVIDED: TAMPER PROOF
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUTALBITAL ACETAMINOPHEN AND CAFFEINE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Parts:
NDC00078-0084-05
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN, MFG P/N
6505012191084
NSN
6505-01-219-1084
NDC00078-0084-05
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN, MFG P/N
6505012191084
NSN
6505-01-219-1084
MFG
SANDOZ INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BUTALBITAL ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 40.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT
FEATURES PROVIDED: TAMPER PROOF
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUTALBITAL ACETAMINOPHEN AND CAFFEINE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1274-01
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN, MFG P/N
6505012191084
NSN
6505-01-219-1084
NDC00182-1274-01
BUTALBITAL,ACETAMINOPHEN,AND CAFFEINE TABLETS,USP
NSN, MFG P/N
6505012191084
NSN
6505-01-219-1084
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS BUTALBITAL ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT AND 40.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT
FEATURES PROVIDED: TAMPER PROOF
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUTALBITAL ACETAMINOPHEN AND CAFFEINE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
099-AL7093
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
099-AL7093
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION USP 3ML MIAL 100S 10 BOXES=1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 100 BOX
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 1000
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
200-39
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
200-39
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
MFG
RESPIRATORY CARE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION USP 3ML MIAL 100S 10 BOXES=1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 100 BOX
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 1000
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
5251
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
5251
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION USP 3ML MIAL 100S 10 BOXES=1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 100 BOX
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 1000
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
ADDIPAK
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
ADDIPAK
SODIUM CHLORIDE INHALATION SOLUTION,USP
NSN, MFG P/N
6505012191091
NSN
6505-01-219-1091
MFG
RESPIRATORY CARE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INHALATION USP 3ML MIAL 100S 10 BOXES=1000S
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 100 BOX
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 1000
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
74506
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505012192760
NSN
6505-01-219-2760
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP 1GM VIAL 10S PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML CAPACITY VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00004-1964-01
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505012192760
NSN
6505-01-219-2760
NDC00004-1964-01
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505012192760
NSN
6505-01-219-2760
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP 1GM VIAL 10S PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML CAPACITY VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ROCEPHIN
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505012192760
NSN
6505-01-219-2760
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP 1GM VIAL 10S PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 10 ML CAPACITY VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00205-2849-02
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505012193273
NSN
6505-01-219-3273
NDC00205-2849-02
ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP
NSN, MFG P/N
6505012193273
NSN
6505-01-219-3273
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS ERYTHROMYCIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE DOSE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00078-0124-60
GLOBULIN,IMMUNE,FOR INJECTION
NSN, MFG P/N
6505012193866
NSN
6505-01-219-3866
NDC00078-0124-60
GLOBULIN,IMMUNE,FOR INJECTION
NSN, MFG P/N
6505012193866
NSN
6505-01-219-3866
MFG
SANDOZ INC
Description
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAINS NOT LESS THAN 96 PERCENT IMMUNE GLOBULIN; WHEN RECONSTITUTED AS DIRECTED SHALL BE CAPABLE OF PRODUCING A STERILE 3 OR 6 PERCENT PROTEIN SOLUTION; PACKAGED WITH A 200 ML VIAL OF SODIUM CHLORIDE INJECTION,USP,AND A DOUBLE-ENDED SPIKE FOR
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: RECONSTITUTION AND DIRECTIONS FOR USE
Related Searches:
SANDOGLOBULIN
GLOBULIN,IMMUNE,FOR INJECTION
NSN, MFG P/N
6505012193866
NSN
6505-01-219-3866
SANDOGLOBULIN
GLOBULIN,IMMUNE,FOR INJECTION
NSN, MFG P/N
6505012193866
NSN
6505-01-219-3866
MFG
SANDOZ INC
Description
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAINS NOT LESS THAN 96 PERCENT IMMUNE GLOBULIN; WHEN RECONSTITUTED AS DIRECTED SHALL BE CAPABLE OF PRODUCING A STERILE 3 OR 6 PERCENT PROTEIN SOLUTION; PACKAGED WITH A 200 ML VIAL OF SODIUM CHLORIDE INJECTION,USP,AND A DOUBLE-ENDED SPIKE FOR
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: RECONSTITUTION AND DIRECTIONS FOR USE
Related Searches:
NDC00182-1427-19
TRIMETHOBENZAMIDE HYDROCHLORIDE SUPPOSITORIES
NSN, MFG P/N
6505012193896
NSN
6505-01-219-3896
NDC00182-1427-19
TRIMETHOBENZAMIDE HYDROCHLORIDE SUPPOSITORIES
NSN, MFG P/N
6505012193896
NSN
6505-01-219-3896
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE INGREDIENT AND STRENGTH: 200.000 TRIMETHOBENZAMIDE HYDROCHLORIDE MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIMETHOBENZAMIDE HYDROCHLORIDE SUPPOSITORIES 200MG ADULT 50S
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GOLDLINE LABS
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 50 SUPPOSITORIES PER PACKAGE
Related Searches:
T-GEN
TRIMETHOBENZAMIDE HYDROCHLORIDE SUPPOSITORIES
NSN, MFG P/N
6505012193896
NSN
6505-01-219-3896
T-GEN
TRIMETHOBENZAMIDE HYDROCHLORIDE SUPPOSITORIES
NSN, MFG P/N
6505012193896
NSN
6505-01-219-3896
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE INGREDIENT AND STRENGTH: 200.000 TRIMETHOBENZAMIDE HYDROCHLORIDE MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIMETHOBENZAMIDE HYDROCHLORIDE SUPPOSITORIES 200MG ADULT 50S
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GOLDLINE LABS
SUPPOSITORY TYPE: ADULT RECTAL
UNIT PACKAGE QUANTITY: 50 SUPPOSITORIES PER PACKAGE
Related Searches:
CYTOXAN
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505012193900
NSN
6505-01-219-3900
CYTOXAN
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505012193900
NSN
6505-01-219-3900
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III WARNING AND CAUTION STATEMENTS: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00015-0549-41
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505012193900
NSN
6505-01-219-3900
NDC00015-0549-41
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505012193900
NSN
6505-01-219-3900
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III WARNING AND CAUTION STATEMENTS: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00143-9977-22
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012193901
NSN
6505-01-219-3901
NDC00143-9977-22
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012193901
NSN
6505-01-219-3901
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5GM VIAL 25S PG
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO INC
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: TWENTY-FIVE 29 ML CAPACITY VIALS PER PKG
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00173-0354-35
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012193901
NSN
6505-01-219-3901
NDC00173-0354-35
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012193901
NSN
6505-01-219-3901
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5GM VIAL 25S PG
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO INC
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: TWENTY-FIVE 29 ML CAPACITY VIALS PER PKG
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC10019-0621-03
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012193901
NSN
6505-01-219-3901
NDC10019-0621-03
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505012193901
NSN
6505-01-219-3901
MFG
BAXTER HEALTHCARE CORP SCIENTIFIC TECHNICAL SYSTEMS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 GRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 1.5GM VIAL 25S PG
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO INC
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.500 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: TWENTY-FIVE 29 ML CAPACITY VIALS PER PKG
TOTAL PRIMARY CONTAINER QUANTITY: 25
